Differences in odor identification among clinical subtypes of Parkinson's disease

European Journal of Neurology

Volumn 18, Issue 3, 2011, Pages 425-429

  Iijima, M ^a   Kobayakawa, T ^b   Saito, S ^c   Osawa, M ^a   Tsutsumi, Y ^a   Hashimoto, S ^a   Uchiyama, S ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c Saito Sachiko Taste and Smell Institute   (Japan)

Author keywords

Clinical subtypes; Odor identification test; Parkinson's disease

Indexed keywords

DEODORANT AGENT;

ADULT; AGE; AGED; AKINESIA; ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE DURATION; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; OLFACTORY DISCRIMINATION; OLFACTORY RECEPTOR; PARKINSON DISEASE; PRIORITY JOURNAL; SEX DIFFERENCE; SMELLING; SMELLING DISORDER; TREMOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; ODORS; OLFACTION DISORDERS; PARKINSON DISEASE; PROGNOSIS; SMELL;

EID: 79951640363     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03167.x     Document Type: Article

References (22)

1. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006; 5: 235-245.
2. Iijima M, Kobayakawa T, Saito S, et al. Smell identification in Japanese Parkinson's disease patients: using the odor stick identification test for Japanese subjects. Intern Med 2008; 47: 1887-1892.
3. Miyamoto T, Miyamoto M, Iwanami M, et al. Odor identification test as a indicator of idiopathic REM sleep behavior disorder. Mov Disord 2009; 24: 268-273.
4. Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988; 38: 1237-1244.
5. Hawkes CH, Shephard BC, Daniel SE. Is Parkinson's disease a primary olfactory disorder? Q J Med 1999; 92: 473-480.
6. Iijima M, Osawa M, Momose M, et.al. Cardiac sympathetic degeneration correlates with olfactory function in Parkinson' s disease. Mov Disord 2010; 25: 1143-1149.
7. Spiegel J, Hellwig D, Farmakis G, et al. Myocardinal sympathetic degeneration correlates with clinical phenotype of Parkinson's disease. Mov Disord 2007; 22: 1004-1008.
8. 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD. J Neurol Sci 2004; 15: 105-111.
9. Suzuki M, Urashima M, Oka H, et al. Cardiac sympathetic denervation in bradykinesia-dominant Parkinson's disease. NeuroReport 2007; 18: 1867-1870.
10. Rajput AH, Voll A, Rajput ML, et al. Course on Parkinson's disease subtypes. Neurology 2009; 73: 206-212.
11. Stern MB, Doty RL, Dotti M, et al. Olfactory function in Parkinson's disease subtypes. Neurology 1994; 44: 266-268.
12. Ondo WG, Lai D. Olfaction testing in Patients with tremor-dominant Parkinson's disease: is this a distinct condition? Mov Disord 2005; 20: 471-475.
13. Verbaan D, Boesveldt S, van Rooden SM, et al. Is olfactory impairment in Parkinson disease related to phenotype or genotypic characteristics? Neurology 2008; 71: 1877-1882.
14. Hughes AJ, Daniel SE, Blankson S, et al. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993; 50: 140-148.
15. Spiegel J, Hellwig D, Samnick S, et al. Striatal FP-CIT uptake differs in the subtypes of early Parkinson' s disease. J Neural Transm 2007; 114: 331-335.
16. Saito S, Ayabe-Kanamura S, Takashima Y, et al. Development of a smell identification test using a novel stick-type odor presentation kit. Chem Senses 2006; 31: 379-391.
17. Siderowf A, Newberg A, Chou KL, et al. [Tc-99m] TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson's disease. Neurology 2005; 64: 1716-1720.
18. Spiegel J, Möllers MO, Jost WH, et al. FP-CIT and MIBG scintigraphy in early Parkinson's disease. Mov Disord 2005; 20: 552-561.
19. 123 I-MIBG and Odor identification in patients with Parkinson's disease and multiple system atrophy. Mov Disord 2006; 21: 1975-1977.
20. Goldstein DS, Sewell L. Olfactory dysfunction in pure autonomic failure: implications for the pathogenesis of Lewy body disease. Parkinsonism Relat Disord 2009; 15: 516-520.
21. Paulus W, Jellinger K. The Neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 1991; 50: 743-755.
22. Rajput AH, Sitte HH, Rajput A, et al. Globus pallidus dopamine and Parkinson motor subtypes. Neurology 2008; 70: 1403-1410.